T. Rowe Price Health Care ETF (TMED US)
TMED US$34.72
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Share price activity
- Last (Price)
- 34.72
- Change
- ▲ 0.16 (0.46)
- Bid / Ask
- 26.98 - 34.87
- Volume
- 400
- Turnover
- 10,434
- Open
- 34.81
- Day Range
- 34.72 - 34.81
- VWAP
- 34.78
- Prev Close
- 34.56
- Last Trade
- 28/10 12:54pm
Fund profile
Fund size
$34.0M
OCT 2026
Distributions
Annually
Since inception
1.4 yrs
JUN 2025
- Legal name
- T. Rowe Price Health Care ETF
- Issuer
- T. Rowe Price
- Type
- Exchange-Traded Fund
- Structure
- Open Ended Investment Company
- Management style
- Actively managed
- Morningstar category
- Health
- Category index
- Morningstar US Health TR USD
- Benchmark
- N/A
- ETF net assets
- $34.0M
- Units on issue
- 1.0M
- Management fee
- 0.44% p.a.
- Domicile
- United States
- Base currency
- USD
- Inception
- 11 JUN 2025
- Listed
- 12 JUN 2025
Objective and strategy
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies. The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities. The fund is non-diversified.
Asset allocation
US equity 96.20%Non-US equity 3.71%
| Asset class | Net % | Long % | Short % |
|---|---|---|---|
| Equity | 99.91 | 99.91 | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Cash | 0.09 | 0.09 | 0.00 |
| Other | 0.00 | 0.00 | 0.00 |
Sector exposure
Cyclical 0.00%Sensitive 0.00%Defensive 100.00%
- Basic Materials
- 0.00%
- Consumer Cyclical
- 0.00%
- Financial Services
- 0.00%
- Real Estate
- 0.00%
- Communication Services
- 0.00%
- Energy
- 0.00%
- Industrials
- 0.00%
- Technology
- 0.00%
- Consumer Defensive
- 0.00%
- Healthcare
- 100.00%
- Utilities
- 0.00%
Region exposure
Developed markets 99.68%Emerging markets 0.33%
- North America
- 96.87%
- Latin America
- 0.00%
- United Kingdom
- 0.21%
- Europe Developed
- 2.59%
- Europe Emerging
- 0.00%
- Africa / Middle East
- 0.00%
- Japan
- 0.00%
- Australasia
- 0.00%
- Asia Developed
- 0.00%
- Asia Emerging
- 0.33%
Country exposure
- United States
- 96.29%
- Switzerland
- 1.78%
- Germany
- 0.63%
- Canada
- 0.58%
- China
- 0.33%
- United Kingdom
- 0.21%
- Italy
- 0.19%
Style box
- Style
- Mid Blend
- Average moat
- Moderate
Size score
130
Value-growth score
151
Economic moat
Wide 44%Narrow 46%None 9%
Market capitalisation
- Giant
- 6.26%
- Large
- 23.05%
- Mid
- 27.30%
- Small
- 25.04%
- Micro
- 18.35%
Giant 6%Large 23%Mid 27%Small 25%Micro 18%
- Average market cap
- $22.80B
- Number of holdings
- 120
- Shares held
- 113
Portfolio statistics · 23 OCT 2026
- Price / earnings
- 31.10
- Price / book
- 3.66
- Price / sales
- 1.59
- Price / cash flow
- 19.74
- Dividend yield
- 0.42%
- Assets in top 10
- 38.69%
- Return on equity
- 8.51%
- Net margin
- 12.12%
Top holdings · top 10 = 39.37% of assets
| Holding | % Weight | First bought | Market value | Currency | Units held | Sector | Country | |
|---|---|---|---|---|---|---|---|---|
| Eli Lilly and Co LLY | 6.17 | JUN 2025 | 2.1M | USD | 1,738 | Healthcare | United States | |
| Alnylam Pharmaceuticals Inc ALNY | 5.78 | JAN 2026 | 1.9M | USD | 7,589 | Healthcare | United States | |
| UnitedHealth Group Inc UNH | 5.27 | JUN 2025 | 1.8M | USD | 4,686 | Healthcare | United States | |
| Thermo Fisher Scientific Inc TMO | 3.78 | SEP 2025 | 1.3M | USD | 1,855 | Healthcare | United States | |
| Cencora Inc COR | 3.44 | JUN 2025 | 1.1M | USD | 3,734 | Healthcare | United States | |
| Insulet Corp PODD | 3.20 | JUL 2025 | 1.1M | USD | 8,035 | Healthcare | United States | |
| Gilead Sciences Inc GILD | 3.17 | JUN 2025 | 1.1M | USD | 6,979 | Healthcare | United States | |
| Agilent Technologies Inc A | 3.03 | JUN 2025 | 1.0M | USD | 5,770 | Healthcare | United States | |
| Intuitive Surgical Inc ISRG | 2.81 | AUG 2026 | 935,649 | USD | 2,270 | Healthcare | United States | |
| Elanco Animal Health Inc ELAN | 2.72 | JUN 2025 | 905,779 | USD | 40,061 | Healthcare | United States |
Trailing returns · 30 SEP 2026
Fund (NAV) Market price
1M
-4.4
3M
-0.8
6M
17.0
YTD
14.1
1Y
27.7
| Period | Fund (NAV) % | Market price % | Before fees % | Rank in category |
|---|---|---|---|---|
| 1 month | -4.38 | -4.22 | -4.34 | 80 / 176 |
| 3 months | -0.76 | -0.62 | -0.65 | 77 / 175 |
| 6 months | 17.00 | 17.33 | 17.26 | 45 / 171 |
| Year to date | 14.08 | 14.19 | 14.46 | 43 / 171 |
| 1 year | 27.70 | 27.91 | 28.26 | 45 / 170 |
Returns to 30 SEP 2026, periods of 3 years and longer annualised. Rank is the percentile in the Morningstar category at 30 SEP 2026 (1 = best) over the funds ranked.
Risk statistics · 30 SEP 2026
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Alpha | 15.44 | — | — | — |
| Beta | 0.52 | — | — | — |
| R-squared | 21.95 | — | — | — |
| Standard deviation | 15.65 | — | — | — |
| Sharpe ratio | 1.41 | — | — | — |
| Sortino ratio | 2.87 | — | — | — |
| Tracking error | 15.44 | — | — | — |
| Information ratio | 0.71 | — | — | — |
| Upside capture % | 82.95 | — | — | — |
| Downside capture % | -40.67 | — | — | — |
| Maximum drawdown % | -5.11 | — | — | — |
Measured against MSCI ACWI NR USD with USTREAS T-Bill Auction Ave 3 Mon as the risk-free rate, to 30 SEP 2026. Maximum drawdown is on gross returns at the latest quarter end.
Portfolio risk score
Risk score
74.8
Morningstar Portfolio Risk Score at 30 SEP 2026.
- Best quarter
- 20.54% · NOV 2025
- Worst quarter
- -2.39% · MAR 2026
Fees and costs
- Management fees and costs
- 0.44% p.a.
- PDS dated
- 1 MAR 2026
Distributions
- Latest distribution
- 0.1616
- Ex Date
- 23 DEC 2025
- Record Date
- 23 DEC 2025
- Pay Date
- 26 DEC 2025
- NAV at ex date
- 29.78
Distributions by year
2024
0.2
| Year | Per unit ($) |
|---|---|
| 2024 | 0.1616 |
Distribution history
| Ex Date | Per unit ($) |
|---|---|
| 23 DEC 2025 | 0.1616 |
Sustainability rating · 31 AUG 2026
Average
ESG risk score
20.98
Category average 21.96
- Rank in category
- 50th percentile of 594 funds
- Environmental risk
- 1.80
- Social risk
- 7.41
- Governance risk
- 3.30
- Portfolio covered
- 92.9%
ESG risk of holdings
- Negligible
- 5.35%
- Low
- 38.94%
- Medium
- 34.93%
- High
- 20.44%
- Severe
- 0.33%
5.51% of assets are in companies with high or severe controversies.
Carbon · 31 AUG 2026
Carbon risk score
2.41
Category average 2.74
- Carbon risk
- Low Risk
- Rank in category
- 39th percentile of 313 funds
- Fossil fuel involvement
- 0.00%
- Category average
- 0.16%
- Low Carbon Designation
- Yes
- Portfolio covered
- 92.4%
Fund managers
- Sal Rais
Tenure
- Number of managers
- 1
- Average tenure
- 1.3 years
- Longest tenure
- 1.3 years
- Longest serving
- Sal Rais · since 11 JUN 2025
- Most recent appointment
- Sal Rais · since 11 JUN 2025
- Managed since
- 11 JUN 2025
- Other funds managed
- 1
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.